Dr. Charles M. Cuerrier is the CEO and co-founder of Spiderwort Inc., a biotechnology company at the forefront of regenerative medicine since its inception in 2015. As a leader and entrepreneur, Dr. Cuerrier is committed to driving breakthrough biotechnologies that address unmet medical needs and transform legacy industries.
Dr. Cuerrier holds a Bachelor’s degree in Medical Biology from Université du Québec à Trois-Rivières and both an MSc and PhD in Pharmacology from Université de Sherbrooke. He completed postdoctoral training in Regenerative Medicine at the University of Ottawa, where he developed Spiderwort’s proprietary biomaterials. Dr. Cuerrier’s academic career is characterized by 15 peer-reviewed publications and several prestigious distinctions, including fellowships from the Fonds de Recherche du Québec – Santé, and awards from the University of Ottawa Heart Institute and the Government of Québec.
With over $20 million CAD in funding raised, Dr. Cuerrier’s leadership has been instrumental in driving Spiderwort’s vision to shape the future of regenerative medicine through the development of cutting-edge cellulose-based biomaterials, with a focus on spinal cord injuries and advancing tissue repair.
Dr. Cuerrier’s work has earned international recognition. As a global speaker, he shares insights on research, entrepreneurship, and biotechnology innovation at industry panels and conferences. Based in Canada, Dr. Cuerrier enjoys spending time with his family in Gatineau, Quebec.
